Implementing the New Medicare Drug Benefit: Continuing Challenges For States
July 12, 2005
Judith D. Moore
This invitation-only Forum session was an update of a 2004 meeting that focused on issues facing states as the new Medicare Drug Benefit is implemented. The facilitated discussion brought together current and former state Medicaid directors and other Medicaid experts to reflect on the current challenges for states in the next six months and in the longer term. Issues related to transitions for dually eligible Medicare and Medicaid beneficiaries, outreach, program enrollment, fiscal impacts, data systems concerns, and coordination of health care services were highlighted.
A Facilitated Discussion, Featuring Current and Former State Officials:
Michael Fogarty, JD, Chief Executive Officer, Oklahoma Health Care Authority; Carol A. Herrmann, Commissioner, Alabama Medicaid Agency; Carolyn Ingram, Director, Medical Assistance Division, New Mexico Department of Human Services; Charles Milligan, JD, Executive Director, Center for Health Program Development and Management, University of Maryland, Baltimore County; James M. Verdier, JD, Senior Fellow, Mathematica Policy Research, Inc.
And Other Medicaid and Medicare Experts:
Gale Arden, Director, Disabled and Elderly Health Programs Group, Center for Medicaid and State Operations, Centers for Medicare & Medicaid Services; Karen Davenport, Washington Director, Medicare Rights Center; Katherine H. Metzger, Director, Medicare and Medicaid Programs, Fallon Community Health Plan
The report from this meeting was published September 22, 2005.